SBRA · Sabra Health Care REIT, Inc.

Track SBRA — free

$20.54 +0.21 (+1.03%) At close · Aug 19

Market Cap

$5.19B

255.46M

Up next

Next earnings call

Nov 7, 2026 Est · unconfirmed · in 11 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Aug 3, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Ask ALVIS about this →

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Buy Momentum Weak Sentiment Bullish Fundamentals Fair Quant / Vol Low

Market backdrop VIX 14.9 · calm Equity put/call 0.52

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +4%

above

Price vs 50-day avg +2%

above

RSI (14) 50

neutral

MACD trend Negative

52-week position 64%

mid-range

Momentum

relative strength

Weak

1-month return −7%

trailing

6-month return −2%

trailing

YTD return +8%

this year

Relative strength −13%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $20 › 200d $20 — 50d above 200d

Institutional flow Accumulating

+0% holders QoQ · +54 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

9.60% of float · ▼ -1.8% MoM · 7.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

464 holders — near 3-yr high, broad support

Squeeze score 63

elevated · 0–100

Fundamentals

Fair

Revenue growth +10%

Y/Y

EPS growth +19%

Y/Y

Valuation P/E 78.2

rich

Balance sheet $2.5B

net debt

Quant / Vol

risk profile

Low

Volatility 24%

annualized · 1-yr

Max drawdown −17%

past year

ATR 2.6%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Feb 12, 2026

Net Income · 2026 $0.60 – $0.64

FFO · 2026 $1.49 – $1.53

Normalized FFO · 2026 $1.49 – $1.53

AFFO · 2026 $1.55 – $1.59

Normalized AFFO · 2026 $1.55 – $1.59

Prior guidance period ended · from the 8-K filed Nov 5, 2025

Net Income · 2025 $0.66 – $0.67

FFO · 2025 $1.47 – $1.48

Normalized FFO · 2025 $1.46 – $1.47

AFFO · 2025 $1.46 – $1.47

Normalized AFFO · 2025 $1.50 – $1.51

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy

1 · 3 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+4% Bullish

Price vs 50-day avg

+2% Bullish

RSI (14)

50 Neutral

MACD trend

Negative Bearish

52-week position

64% Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $20 › 200d $20 — 50d above 200d

Institutional flow Accumulating

+0% holders QoQ · +54 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

9.60% of float · ▼ -1.8% MoM · 7.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

464 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $17 Now $21 · 64% Range high $22

vs 200-day avg +4% vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Beds/units	37,043	as of June 30, 2026	—
Behavioral health facilities	16	as of June 30, 2026	—
Cash NOI (Same Store) non-GAAP	$28.56M	Three Months Ended June 30, 2026	—
Cash NOI - Consolidated Senior Housing - Managed non-GAAP	$40.07M	Three Months Ended June 30, 2026	—
Consolidated Enterprise Value	$7.9B	As of June 30, 2026	—
Cost of Permanent Consolidated Debt non-GAAP	3.92%	As of June 30, 2026	—
Debt as a % of Asset Value	37%	As of June 30, 2026	—
Interest savings from hedged variable rate exposure	$7M	last 12 months	—
Investments	395	As of June 30, 2026	—
Investments in loans receivable	11	as of June 30, 2026	—
Liquidity	$1.3B	As of June 30, 2026	—
Real estate properties held for investment	364	as of June 30, 2026	—
Relationships	61	As of June 30, 2026	—
Same property managed senior housing Cash NOI (year-over-year) non-GAAP	13.7%	Q2 2026	—

Senior housing - leased communities	32	as of June 30, 2026	—
Senior housing - managed communities	94	as of June 30, 2026	—
Skilled Mix	39%	As of June 30, 2026	—
Skilled nursing/transitional care facilities	207	as of June 30, 2026	—
Specialty hospitals and other facilities	15	as of June 30, 2026	—
Unencumbered Assets/Unsecured Debt non-GAAP	265%	As of June 30, 2026	—
Weighted average effective interest rate on permanent debt	3.92%	As of June 30, 2026	—
Weighted average number of common shares outstanding, diluted - AFFO and Normalized AFFO non-GAAP	256,733,670	Three Months Ended June 30, 2026	—
Weighted average number of common shares outstanding, diluted - Normalized FFO non-GAAP	255,912,180	Three Months Ended June 30, 2026	—
Workforce diversity - ethnic minorities self-identified	34%	As of June 30, 2026	—
Workforce diversity - women in management/leadership roles	58%	As of June 30, 2026	—
Workforce diversity - women in workforce	55%	As of June 30, 2026	—
Wtd. Avg. Remaining Lease Term	7	As of June 30, 2026	—
EBITDARM Coverage - Senior Housing - Leased non-GAAP	1.58	Q1 2026	—

EBITDARM Coverage - Skilled Nursing/Transitional Care non-GAAP	2.46	Q1 2026	—

Net Debt to Adjusted EBITDA non-GAAP	5.04	Q1 2026	—
Same property managed senior housing Cash NOI growth non-GAAP	14.4%	Q1 2026	—
Adjusted EBITDA, as adjusted non-GAAP	$123.9M	Three Months Ended December 31, 2025	—
Adjusted EBITDA, as adjusted, annualized non-GAAP	$495.61M	As of December 31, 2025	—
EBITDARM Coverage - Behavioral Health, Specialty Hospitals and Other non-GAAP	3.99	Q4 FY2025	—
Net Debt non-GAAP	$2.48B	As of December 31, 2025	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

REIT - Healthcare Facilities — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
SBRA Sabra Health Care REIT, Inc. this stock	$5.19B	+8.4%	+10.2%	78.2	9.6%
WELL Welltower Inc.	$166.20B	+27.0%	+35.6%	117.1	2.5%
VTR Ventas, Inc.	$46.78B	+18.7%	+18.5%	168.9	4.6%
DOC Healthpeak Properties, Inc.	$14.24B	+29.1%	+4.5%	59.0	3.5%
OHI Omega Healthcare Investors Inc	$14.11B	+5.8%	+13.2%	16.6	4.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

464

% held: 102.0%
Net QoQ: +1.9M sh
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

439

View

Short & Settlement

Short Interest Falling

Shares short

24.5M

Days to cover: 7.4d
Change: -450.3K sh

View

Short Volume

Short vol %

46%

As of: Aug 19, 2026

Short Total

View

Fails to Deliver

FTD shares

179

Value: $3.5K
As of: Jul 16, 2026

View

Off-Exchange

Off-exchange %

31.9%

Week of: Jul 13, 2026

Off-exch Lit

View

Smart Money

Congressional Trades Sell

Member

Daniel Goldman

Amount: $1.0K–$15.0K
Traded: Apr 10, 2023

View

Financials

Revenue (FY)

$774.6M

Net income (FY): $155.6M
EPS diluted: $0.64

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 3, 2026
This year: 11

View

Proposed Sales

Value

$192.5K

Shares: 11.0K
Filed: May 15, 2025

View

Earnings & Events

Earnings Calls

Last call

Aug 4, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
SBRA	+1.7%	-6.6%	-1.5%	-3.0%	+8.5%
SPY	-0.4%	+2.9%	+11.6%	+3.0%	+12.8%
vs SPY	+2.2%	-9.5%	-13.1%	-5.9%	-4.3%

Capital returns

Latest dividend

$0.30 / share · ex Aug 14, 2026

Cut 33.3%

Paid (TTM)

$1.20 / share · 4 payouts

Dividend yield (TTM, derived)

5.84%

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1492298 CUSIP 78573L106 13F (30d) 421 filings 415 filers Visit website Investor relations

SBRA · Sabra Health Care REIT, Inc.

Price & Indicators

Up next

AI Brief

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns